Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)
J Neurol. 2024 Mar;271(3):1473-1482.
doi: 10.1007/s00415-023-12105-2.
Epub 2023 Dec 6.
1 Department of Dermatology, Hospital Dupuytren 2, UHC of Limoges, Limoges, France.
2 Department of Medical Neurology, Hospital Pellegrin, UHC of Bordeaux, Bordeaux, France.
3 Department of Dermatology, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France.
4 BRIC (Bordeaux Institute of Oncology), UMR1312, INSERM, Univ. Bordeaux, 33000, Bordeaux, France.
5 Department of Dermatology, UHC of Nantes, France, CIC 1413, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, 44000, Nantes, France.
6 Department of Dermatology, UHC of Lyon, Lyon, France.
7 Department of Dermatology, Hospital Avicenne, AP-HP, Paris, France.
8 Department of Dermatology, UHC of Besançon, Besançon, France.
9 Department of Oncology, Cancer Comprehensive Center, Saint-Herblain, France.
10 Department of Dermatology, Military Training Hospital of Sainte Anne, Toulon, France.
11 Department of Dermatology, UHC of Grenoble, Grenoble, France.
12 Department of Dermatology, Estaing Hospital, Clermont-Ferrand, France.
13 Department of Dermatology, Hôpital Saint-André, CHU de Bordeaux, Bordeaux, France. [email protected].
14 BRIC (Bordeaux Institute of Oncology), UMR1312, INSERM, Univ. Bordeaux, 33000, Bordeaux, France. [email protected].